ES557625A0 - Procedimiento para preparar nuevos derivados 2,3-difenilicos de esteres -8-nitrilos - Google Patents

Procedimiento para preparar nuevos derivados 2,3-difenilicos de esteres -8-nitrilos

Info

Publication number
ES557625A0
ES557625A0 ES557625A ES557625A ES557625A0 ES 557625 A0 ES557625 A0 ES 557625A0 ES 557625 A ES557625 A ES 557625A ES 557625 A ES557625 A ES 557625A ES 557625 A0 ES557625 A0 ES 557625A0
Authority
ES
Spain
Prior art keywords
diphenylic
derivatives
procedure
preparing new
nitrile esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557625A
Other languages
English (en)
Other versions
ES8802490A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Laboratoires Hoechst SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Hoechst SA filed Critical Laboratoires Hoechst SA
Publication of ES8802490A1 publication Critical patent/ES8802490A1/es
Publication of ES557625A0 publication Critical patent/ES557625A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES557625A 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 2,3-difenilicos de esteres -8-nitrilos Expired ES8802490A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8505123A FR2587339B1 (fr) 1985-04-04 1985-04-04 Nouveaux medicaments constitues par des derives-2,3 ou -3,4 diphenyles des esters g-nitriles ou leurs produits de cyclisation et procedes pour les preparer

Publications (2)

Publication Number Publication Date
ES8802490A1 ES8802490A1 (es) 1988-07-01
ES557625A0 true ES557625A0 (es) 1988-07-01

Family

ID=9317941

Family Applications (4)

Application Number Title Priority Date Filing Date
ES553642A Expired ES8802219A1 (es) 1985-04-04 1986-04-02 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres de p-nitrilos.
ES557626A Expired ES8802491A1 (es) 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 3,4-difenilicos de esteres -8-nitrilos
ES557625A Expired ES8802490A1 (es) 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 2,3-difenilicos de esteres -8-nitrilos
ES557801A Expired ES8802221A1 (es) 1985-04-04 1988-01-15 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres-j-nitrilos

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES553642A Expired ES8802219A1 (es) 1985-04-04 1986-04-02 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres de p-nitrilos.
ES557626A Expired ES8802491A1 (es) 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 3,4-difenilicos de esteres -8-nitrilos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557801A Expired ES8802221A1 (es) 1985-04-04 1988-01-15 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres-j-nitrilos

Country Status (11)

Country Link
US (1) US4785007A (es)
EP (1) EP0203308A2 (es)
JP (1) JPS61229854A (es)
KR (1) KR860008139A (es)
AU (1) AU5561786A (es)
DK (1) DK151586A (es)
ES (4) ES8802219A1 (es)
FR (1) FR2587339B1 (es)
GR (1) GR860891B (es)
PT (1) PT82333B (es)
ZA (1) ZA862458B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI875101A (fi) * 1986-12-03 1988-06-04 Tanabe Seiyaku Co Laktamderivat och preparat innehaollande dessa.
JP4943429B2 (ja) * 2005-07-22 2012-05-30 メルク・シャープ・エンド・ドーム・コーポレイション カリウムチャネル阻害剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE765203C (de) * 1939-08-02 1953-06-01 Ig Farbenindustrie Ag Verfahren zur Herstellung von Piperidonen und Piperidinen
US3468893A (en) * 1966-03-14 1969-09-23 Ciba Geigy Corp 1-substituted-diphenyl-azacycloalkenes
US3956314A (en) * 1970-07-24 1976-05-11 U.C.B., Societe Anonyme Derivatives of 2-pyrrolidinone
US3814771A (en) * 1970-11-19 1974-06-04 T Shen 5-phenyl-2-piperidones and 5-phenyl-2-thiopiperidones
US3718743A (en) * 1970-11-19 1973-02-27 Merck & Co Inc 5-phenyl-2-piperidones and 5-phenyl-2-thiopiperidones in compositions and methods for treating pain, fever and inflammation
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams

Also Published As

Publication number Publication date
ZA862458B (en) 1986-11-26
ES557801A0 (es) 1988-04-16
DK151586D0 (da) 1986-04-03
DK151586A (da) 1986-10-05
ES553642A0 (es) 1988-04-16
EP0203308A2 (de) 1986-12-03
KR860008139A (ko) 1986-11-12
PT82333B (fr) 1988-04-07
FR2587339A1 (fr) 1987-03-20
FR2587339B1 (fr) 1988-08-05
GR860891B (en) 1986-08-04
ES8802221A1 (es) 1988-04-16
ES8802491A1 (es) 1988-07-01
PT82333A (fr) 1986-05-01
ES8802219A1 (es) 1988-04-16
AU5561786A (en) 1986-10-09
ES557626A0 (es) 1988-07-01
ES8802490A1 (es) 1988-07-01
JPS61229854A (ja) 1986-10-14
US4785007A (en) 1988-11-15

Similar Documents

Publication Publication Date Title
MX159807A (es) Procedimiento para preparar derivados de bencimidazol
ES548921A0 (es) Procedimiento para preparar nuevos derivados de aminotetra- lina
NO167034C (no) Fremgangsmaate for fremstilling av 1,6-diklor-1,6-dideoksy-beta-d-fruktofuranosyl-4-kloro-4-dioksy-alfa-galactopyranosid
ES553989A0 (es) Procedimiento para preparar 2,2,6,6-tetraalquil-4-piperidilaminas
ES557241A0 (es) Procedimiento para preparar nuevos 2-aril-imidazoles
ES540464A0 (es) Procedimiento para preparar derivados de pleuromutilina
ES557522A0 (es) Procedimiento para preparar derivados de cinolina
ES550875A0 (es) Procedimiento para preparar derivados de imidazolilalquil- quilguanidina
ES552032A0 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
MX159654A (es) Procedimiento para preparar derivados de hidroxi-4-2h-1-benzotiopiran-2-onas
ES552955A0 (es) Procedimiento para preparar derivados de bencimidazol substituidos
MX161397A (es) Procedimiento para preparar derivados de 1,3 oxazolidin-2-ona
ES550961A0 (es) Procedimiento para preparar derivados azolilalquilicos
ES553851A0 (es) Procedimiento para preparar derivados de nitrofurano
ES543985A0 (es) Procedimiento para preparar derivados de butiramida
ES549076A0 (es) Procedimiento para preparar derivados de fenilpiperazina
ES549378A0 (es) Procedimiento para la preparacion de derivados de 1,3,4-tia-diazol
ES557625A0 (es) Procedimiento para preparar nuevos derivados 2,3-difenilicos de esteres -8-nitrilos
ES557069A0 (es) Procedimiento para preparar derivados de benzazol
ES554828A0 (es) Procedimiento para preparar derivados de fluoralcanos.
ES555036A0 (es) Procedimiento para preparar derivados de oxadiazolilimidazobenzodiazepina
ES541140A0 (es) Procedimiento para preparar derivados carboxialquildipepti- dicos
ES543014A0 (es) Procedimiento para preparar nuevos derivados de quinoleina
ES554339A0 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina
ES539891A0 (es) Procedimiento para preparar derivados de citidina-difosfato-colina